| Literature DB >> 16876317 |
Katy E Beck1, Luigi A De Girolamo, Martin Griffin, E Ellen Billett.
Abstract
Tissue transglutaminase (TG2) can induce post-translational modification of proteins, resulting in protein cross-linking or incorporation of polyamines into substrates, and can also function as a signal transducing G protein. The role of TG2 in the formation of insoluble cross-links has led to its implication in some neurodegenerative conditions. Exposure of pre-differentiated SH-SY5Y cells to the Parkinsonian neurotoxin 1-methyl-4-phenylpyridinium ion (MPP(+)) resulted in significant dose-dependent reductions in TG2 protein levels, measured by probing Western blots with a TG2-specific antibody. Transglutaminase (TG) transamidating activity, on the other hand, monitored by incorporation of a polyamine pseudo-substrate into cellular proteins, was increased. Inhibitors of TG (putrescine) and TG2 (R283) exacerbated MPP(+) toxicity, suggesting that activation of TG2 may promote a survival response in this toxicity paradigm.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16876317 DOI: 10.1016/j.neulet.2006.06.061
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046